4 / 18
Inst itut Català d'Oncologia
Institut Català d’Oncol gia
Checkmate 141: Overall survival by PD-L1 expression
•EPAR OPDIVO. EMA/CHMP/271863/2017
• Tumor PD-L1 expression status could be evaluated in 260 of 361 patients (72.0%)
• PDL ≥1: 57.3%
Tumor PD-L1 – Dako 28-8
•Ferris RL, et al.
N Engl J Med
2016;375:1856–1867.
N=149
N=111